The CCR5 Patent(s)
The CCR5 Patent(s)
This chapter explores how the CCR5 gene was patented by several companies both in the United States and in Europe. It discusses how one of the patent holders patented the incorrect sequence and did not know the precise function of the gene’s product. The patenting of the gene illustrates how lenient the United States Patent and Trademark Office (USPTO) was in granting gene patents back in the 1990s with a view to encourage growth in the biotechnology sector. It also discusses the views of numerous biomedical researchers on the patenting of the gene by sequencing companies.
Keywords: Human Genome Sciences, Inc, Euroscreen, gene patents, United States Patent and Trademark Office, European Patent Office
MIT Press Scholarship Online requires a subscription or purchase to access the full text of books within the service. Public users can however freely search the site and view the abstracts and keywords for each book and chapter.
Please, subscribe or login to access full text content.
If you think you should have access to this title, please contact your librarian.
To troubleshoot, please check our FAQs, and if you can't find the answer there, please contact us.
